Cilostazol: Clinical Trials

30 trials of Cilostazol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 10 unknown, 4 recruiting, 3 not yet recruiting. 30 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 330Completed 11, Unknown 10, Recruiting 4, Not yet recruiting 3, Terminated 2
Phase 23Completed 3

Follow Cilostazol: new trials by email Literature Review of Cilostazol trials Research Report on Cilostazol

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cilostazol for Prevention of Recurrent Stroke Trial
Cilostazol 100 mg Tablets, Placebo - Stroke Recurrence, Myocardial Infarction
Phase 3Not yet recruitingStanford University20002026-10-012026-10-26
CiLostAzol for pReventIon of Recurrent sTroke in Africa
Cilostazol 100 mg - Stroke
Phase 3Not yet recruitingNorthern California Institute of Research and Education11002026-08-012026-06-18
Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage
Cilostazol (PletalĀ®) 100 mg Tablets, Placebo, Nimodipine group - Aneurysmal Subarachnoid Hemorrhage
Phase 3Not yet recruitingCentre Hospitalier St Anne6302025-12-152025-09-10
Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage
Cilostazol 100 mg BID, placebo - Aneurysmal Subarachnoid Hemorrhage
Phase 3RecruitingBeijing Tiantan Hospital3802025-12-062026-10-16
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
Cilostazol / Ginko Leaf Dried Ext., Placebo - Type 2 Diabets Mellitus, Cognitive Ability, General
Phase 3RecruitingSeoul National University Bundang Hospital802025-01-012025-05-25
Ticagrelor Versus Cilostazol in Ischemic Stroke
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University9002024-08-302024-08-20
Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA
Ticagrelor 90 MG, Cilostazol 100 MG, Aspirin 75mg - Ischemic Stroke
Phase 3RecruitingKafrelsheikh University9002024-08-102025-09-18
Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds
Cilostazol, Aspirin - Cerebral Microbleeds, Stroke
Phase 3RecruitingZhejiang Provincial People's Hospital8482024-07-182024-07-31
Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University5802024-03-302024-08-20
Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIA
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University9002023-12-012024-08-20
Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients
Cilostazol, Selenium - Wound Heal
Phase 2 / Phase 3CompletedAin Shams University2062023-10-192025-02-18
Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
Clopidogrel tablet, Cilostazol 100 MG - Ischemic Stroke
Phase 3CompletedKafrelsheikh University5802023-01-012024-08-20
The Effect of Cilostazol on Rheumatoid Arthritis Patients
Cilostazol 100 MG, conventional synthetic antirheumatic drugs - Rheumatoid Arthritis
Phase 2 / Phase 3CompletedAin Shams University702022-11-012026-01-02
Cilostazol and Methotrexate in Rheumatoid Arthritis
Cilostazol, Methotrexate, Placebo - Rheumatoid Arthritis
Phase 3UnknownTanta University702022-10-012024-04-10
Clopidogrel Versus Cilostazol in Ischemic Stroke
Clopidogrel tablet, Cilostazol 100 MG - Ischemic Stroke
Phase 3CompletedKafrelsheikh University8702022-06-012024-09-19
Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA
Cilostazol 100 MG, Clopidogrel - Ischemic Stroke
Phase 3UnknownKafrelsheikh University8702022-05-012024-09-19
Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA
Cilostazol 100 MG, Clopidogrel 75mg - Ischemic Stroke
Phase 3UnknownKafrelsheikh University8702022-04-152024-09-19
Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA
Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke
Phase 3UnknownKafrelsheikh University9002022-02-092024-09-19
LACunar Intervention (LACI-2) Trial-2
Isosorbide Mononitrate XL (ISMN), Cilostazol, ISMN XL and Cilostazol - Cerebral Small Vessel Diseases, Stroke, Lacunar
Phase 2 / Phase 3CompletedUniversity of Edinburgh3632018-01-082024-11-12
Cilostazol Following Peripheral Endovascular Procedures
Cilostazol, Aspirin - Peripheral Arterial Disease
Phase 3UnknownAttikon Hospital2002016-12-012021-01-12

Showing 20 of 30. Sign in to see all of them.

Conditions studied

Ischemic Stroke (10)  ·  Stroke (4)  ·  Angina Pectoris, Variant (2)  ·  Arthritis, Rheumatoid (2)  ·  Cerebral Infarction (2)  ·  Peripheral Arterial Disease (2)  ·  Subarachnoid Hemorrhage (2)  ·  Alzheimer Disease (1)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Coronary Artery Disease (1)  ·  Coronary Stenosis (1)  ·  Dementia (1)

Sponsors

Kafrelsheikh University (9)  ·  Ain Shams University (2)  ·  Korea Otsuka Pharmaceutical Co., Ltd. (2)  ·  Seoul National University Bundang Hospital (2)  ·  Attikon Hospital (1)  ·  Beijing Tiantan Hospital (1)  ·  Centre Hospitalier St Anne (1)  ·  Genovate Biotechnology Co., Ltd., (1)  ·  Gyeongsang National University Hospital (1)  ·  Jong Woo Chung (1)  ·  Joselyn Cerezo, MD (1)  ·  Northern California Institute of Research and Education (1)  ·  Otsuka Beijing Research Institute (1)  ·  Otsuka Pharmaceutical Co., Ltd. (1)  ·  Stanford University (1)

Countries

Egypt (12)  ·  South Korea (6)  ·  China (3)  ·  Japan (2)  ·  United States (2)  ·  Canada (1)  ·  Ghana (1)  ·  Greece (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Chern-En Chiang, M.D., Ph.D. (1)  ·  Don Cutlip, MD (1)  ·  Elias Brountzos, MD, PhD, EBIR (1)  ·  Jen-Kuang Lee, M.D. (1)  ·  Jen-Yuan Kuo, M.D. (1)  ·  Joanna M Wardlaw, MB ChB (1)  ·  Jong Woo Chung, MD (1)  ·  Junghong Kim, MD (1)  ·  Maarten Lansberg, MD, PhD (1)  ·  Ming-Shien Wen, M.D. (1)  ·  Mohamed Ismaiel, MSc (1)  ·  Nobuyuki Sakai, M.D. PhD (1)

Results publications

PMID 31867054, PMID 18190818, PMID 2375765, PMID 12807523, PMID 11914403, PMID 17636626, PMID 1830180, PMID 18456558, PMID 18779447, PMID 19506373, PMID 20150545, PMID 20350366, PMID 20650435, PMID 21125444, PMID 21640651, PMID 21677432, PMID 21947244, PMID 22090168, PMID 22879655, PMID 22949472, PMID 23517020, PMID 25358850, PMID 25389284, PMID 25487817, PMID 26386103, PMID 27070952, PMID 27494819, PMID 27637674, PMID 29778364, PMID 30341966, PMID 30511260, PMID 31122494, PMID 31394993, PMID 33860901, PMID 34515113, PMID 35833913, PMID 36450971, PMID 37212182, PMID 37222252, PMID 37665377, PMID 40220202, PMID 40232632, PMID 40380042, PMID 41495844

NIH funding

1UG3NS133209-01A1 (1), 2016 (1), U01HL077221 (1), U01HL081656 (1)